Cefuroxime — Class III drug recall D-0246-2018
Terminated recall by JCB Laboratories LLC, reported 2018-02-07, distributed nationwide. Subpotent Drug: The product is sub-potent prior to its 90-day beyond use date.
| Recall number | D-0246-2018 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | JCB Laboratories LLC, Wichita, KS, United States |
| Recall initiated | 2018-01-24 |
| Classified | 2018-01-30 |
| Reported by FDA | 2018-02-07 |
| Terminated | 2020-08-03 |
| Distributed | Nationwide (US) |
| Quantity | 6,510 syriges |
| Reason classes | potency |
| Lot numbers | C274-000002725, C274-000002790, C274-000002989, C274-000003008, C274-000003077 |
| Expiration dates | 2018-01-21, 2018-01-28, 2018-02-13, 2018-02-14, 2018-02-20 |
Product
Cefuroxime, Ophthalmic Solution for Injection, 10 mg/mL, 0.3 mL single-use syringe. This is a Compounded Drug, Hospital & Office Use Only, Not for Resale. Fagron Sterile Services/JCB Laboratories, 7335 W. 33rd St. N., Wichita, KS 67205
Reason for recall
Subpotent Drug: The product is sub-potent prior to its 90-day beyond use date.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0246-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.